ASTELLAS PHARMA US, INC. for ASTELLAS PHARMA US, INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
House and Senate Appropriations for Fiscal Year ending Sept 30, 2019.
Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH DEVANEY | — |
| VALARIE MOLAISON | — |
| MARY LACEY REUTHER | — |
Copyright/Patent/Trademark CPT
Biopharmaceutical innovation and patent policy issues; Affordable Prescriptions for Patients Act of 2019 (S.1416).
Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH DEVANEY | — |
| VALARIE MOLAISON | — |
| MARY LACEY REUTHER | — |
Health Issues HCR
Value of Prescription Drugs, Senate & House; Issues related to march-in rights under Bayh-Dole Act (Pub. L. 96-517).
Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH DEVANEY | — |
| VALARIE MOLAISON | — |
| MARY LACEY REUTHER | — |
Medicare/Medicaid MMM
Issues related to Medicare Part D policies, including non-interference and rebate policy issues. Drug costs and pricing policy issues. Transparency policy issues. H.R. 3 "Lower Drug Costs Now Act of 2019."
Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH DEVANEY | — |
| VALARIE MOLAISON | — |
| MARY LACEY REUTHER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.